Researchers are excited about this new drug, a novel dual treatment showing remarkable results in initial trials for size loss . It works by modulating two pathways : GLP-1 and GIP, which , when stimulated, assist control appetite and improve energy expenditure . Early reports demonstrate noteworthy weight loss and potential advantages for people s